The impact of an antifungal stewardship team on voriconazole therapeutic drug monitoring in a UK tertiary hospital

被引:1
|
作者
Jones, M. [1 ]
Micallef, C. [1 ,2 ]
Tyler, N. [1 ]
Wong, V. K. [2 ]
Enoch, D. A. [2 ]
机构
[1] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Pharm Dept, Cambridge, England
[2] Publ Hlth England, Addenbrookes Hosp, Clin Microbiol & Publ Hlth Lab, Natl Infect Serv, Cambridge, England
关键词
D O I
10.1016/j.jinf.2021.07.023
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:E9 / E11
页数:3
相关论文
共 50 条
  • [41] Therapeutic drug monitoring of antifungal agents
    Lewis J.S., II
    Current Fungal Infection Reports, 2009, 3 (2) : 96 - 102
  • [42] Benchmarking voriconazole therapeutic drug monitoring in adults and paediatrics
    Ishak, Yostina
    Oakley, Robert
    Yau, Ting
    JAC-ANTIMICROBIAL RESISTANCE, 2024, 6
  • [43] Impact of Voriconazole Therapeutic Drug Monitoring on Adverse Effects and Clinical Outcomes: A Literature Review
    Clary, Ryan T.
    Deja, Erin
    Rittmann, Barry
    Bearman, Gonzalo
    CURRENT INFECTIOUS DISEASE REPORTS, 2025, 27 (01)
  • [44] Voriconazole therapeutic drug monitoring: Factors associated with supratherapeutic and subtherapeutic voriconazole concentrations
    You, Haisheng
    Dong, Yuzhu
    Zou, Yamin
    Zhang, Tao
    Lei, Jin'e
    Chen, Limei
    Wang, Xue
    Dong, Yalin
    Wang, Taotao
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2018, 56 (05) : 239 - 246
  • [45] Impact of voriconazole therapeutic drug monitoring (tdm) on toxicity avoidance in immunocompromised hematological patients
    Vaca Recalde, G.
    Nogueiras Alvarez, R.
    Mazon Marana, I.
    Illaro Uranga, A.
    Yanez San Segundo, L.
    Vega Gil, N.
    Bautista Blazquez, A.
    Cuellar Gomez, D. Z.
    Ortiz Petrosino, P.
    Sanchez Santiago, M. B.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 : S11 - S12
  • [46] Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis
    Sarfati, Sacha
    Wils, Julien
    Lambert, Timothee
    Mory, Celine
    Imbert, Laurent
    Gargala, Gilles
    Morisse-Pradier, Helene
    Lamoureux, Fabien
    PHARMACEUTICS, 2022, 14 (08)
  • [47] Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study
    Whitley M. Yi
    Kelly E. Schoeppler
    Jaclyn Jaeger
    Scott W. Mueller
    Robert MacLaren
    Douglas N. Fish
    Tyree H. Kiser
    Annals of Clinical Microbiology and Antimicrobials, 16
  • [48] Therapeutic drug monitoring and safety of voriconazole in elderly patients
    Cheng, Lin
    Xiang, Rongfeng
    Liu, Fang
    Li, Yuliang
    Chen, Heli
    Yao, Pu
    Sun, Fengjun
    Xia, Peiyuan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 78
  • [49] Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study
    Yi, Whitley M.
    Schoeppler, Kelly E.
    Jaeger, Jaclyn
    Mueller, Scott W.
    MacLaren, Robert
    Fish, Douglas N.
    Kiser, Tyree H.
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2017, 16
  • [50] Voriconazole Therapeutic Drug Monitoring Practices in Intensive Care
    van Wanrooy, Marjolijn J. P.
    Rodgers, Michael G. G.
    Span, Lambert F. R.
    Zijlstra, Jan G.
    Uges, Donald R. A.
    Kosterink, Jos G. W.
    van der Werf, Tjip S.
    Alffenaar, Jan-Willem C.
    THERAPEUTIC DRUG MONITORING, 2016, 38 (03) : 313 - 318